VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans

被引:91
作者
Limdi, Nita A. [1 ]
Beasley, T. Mark [2 ]
Crowley, Michael R. [3 ]
Goldstein, Joyce A. [4 ]
Rieder, Mark J. [5 ]
Flockhart, David A. [6 ]
Arnett, Donna K. [7 ]
Acton, Ronald T. [8 ]
Liu, Nianjun [2 ]
机构
[1] Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Genet, Birmingham, AL 35294 USA
[4] NIEHS, Lab Pharmacol & Chem, Res Triangle Pk, NC USA
[5] Univ Washington, Dept Genome Sci, Washington, DC USA
[6] Indiana Univ, Sch Med, Div Clin Pharmacol, Bloomington, IN 47405 USA
[7] Univ Alabama, Dept Epidemiol, Birmingham, AL USA
[8] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA
关键词
African-Americans; cohort study; CYP2C9; European-Americans; pharmacogenetics; VKORC1; haplotypes; warfarin;
D O I
10.2217/14622416.9.10.1445
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Although the influence of VKORC1 and CYP2C9 polymorphisms on warfarin response has been studied, variability in dose explained by CYP2C9 and VKORC1 is lower among African-Americans compared with European-Americans. This has lead investigators to hypothesize that assessment of VKORC1 haplotypes may help capture a greater proportion of the variability in dose for this under-represented group. However, the inadequate representation of African-Americans and the assessment of a few VKORC1 polymorphisms have hindered this effort. Methods: To determine if VKORC1 haplotypes or haplotype groups explain a higher variability in warfarin dose, we comprehensively assessed VKORC1 polymorphisms in 273 African-Americans and 302 European-Americans. The influence of VKORC1 polymorphisms, race-specific haplotypes and haplotype groups on warfarin dose was evaluated in race-stratified multivariable analyses after accounting for CYP2C9 (*2, *3, *5, *6 and *11) and clinical covariates. Results: VKORC1 explained 18% (30% with CYP2C9) variability in warfarin dose among European-Americans and 5% (8% with CYP2C9) among African-Americans. Four common haplotypes in European-Americans and twelve in African-Americans were identified. In each race VKORC1 haplotypes emerged into two groups: low-dose (Group A) and high-dose (Group 13). African-Americans had a lower frequency of Group A haplotype (10.6%) compared with European-Americans (35%, p < 0.0001). The variability in dose explained by VKORC1 haplotype or haplotype groups was similar to that of a single informative polymorphism. Conclusions: Our findings support the use of CYP2C9, VKORC1 polymorphisms (rs9934438 or rs9923231) and clinical covariates to predict warfarin dose in both African- and European-Americans. A uniform set of common polymorphisms in CYP2C9 and VKORC1, and limited clinical covariates can be used to improve warfarin dose prediction for a racially diverse population.
引用
收藏
页码:1445 / 1458
页数:14
相关论文
共 49 条
  • [1] Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation
    Anderson, Jeffrey L.
    Horne, Benjamin D.
    Stevens, Scott M.
    Grove, Amanda S.
    Barton, Stephanie
    Nicholas, Zachery P.
    Kahn, Samera F. S.
    May, Heidi T.
    Samuelson, Kent M.
    Muhlestein, Joseph B.
    Carlquist, John F.
    [J]. CIRCULATION, 2007, 116 (22) : 2563 - 2570
  • [2] [Anonymous], PHYLIP HOME PAGE
  • [3] Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P4502C9 gene polymorphisms on warfarin dose requirements
    Aquilante, CL
    Langaee, TY
    Lopez, LM
    Yarandi, HN
    Tromberg, JS
    Mohuczy, D
    Gaston, KL
    Waddell, CD
    Chirico, MJ
    Johnson, JA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (04) : 291 - 302
  • [4] Cytochrome P4502C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity
    Bodin, L
    Verstuyft, C
    Tregouet, DA
    Robert, A
    Dubert, L
    Funck-Brentano, C
    Jaillon, P
    Beaune, P
    Laurent-Puig, P
    Becquemont, L
    Loriot, MA
    [J]. BLOOD, 2005, 106 (01) : 135 - 140
  • [5] Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians
    Borgiani, Paold
    Ciccacci, Cinzia
    Forte, Vittorio
    Romano, Silvia
    Federici, Giorgio
    Novelli, Giuseppe
    [J]. PHARMACOGENOMICS, 2007, 8 (11) : 1545 - 1550
  • [6] CYP4F2 genetic variant alters required warfarin dose
    Caldwell, Michael D.
    Awad, Tarif
    Johnson, Julie A.
    Gage, Brian F.
    Falkowski, Mat
    Gardina, Paul
    Hubbard, Jason
    Turpaz, Yaron
    Langaee, Taimour Y.
    Eby, Charles
    King, Cristi R.
    Brower, Amy
    Schmelzer, John R.
    Glurich, Ingrid
    Vidaillet, Humberto J.
    Yale, Steven H.
    Zhang, Kai Qi
    Berg, Richard L.
    Burmester, James K.
    [J]. BLOOD, 2008, 111 (08) : 4106 - 4112
  • [7] Evaluation of Genetic Factors for Warfarin Dose Prediction
    Caldwell, Michael D.
    Berg, Richard L.
    Zhang, Kai Qi
    Glurich, Ingrid
    Schmelzer, John R.
    Yale, Steven H.
    Vidaillet, Humberto J.
    Burmester, James K.
    [J]. CLINICAL MEDICINE & RESEARCH, 2007, 5 (01) : 8 - 16
  • [8] Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose:: a prospective study
    Carlquist, John F.
    Horne, Benjamin D.
    Muhlestein, Joseph B.
    Lappe, Donald L.
    Whiting, Bryant M.
    Kolek, Matthew J.
    Clarke, Jessica L.
    James, Brent C.
    Anderson, Jeffrey L.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2006, 22 (03) : 191 - 197
  • [9] Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients
    Cho, Hyun-Jung
    Sohn, Kie-Ho
    Park, Hyang-Mi
    Lee, Kyung-Hoon
    Choi, Bo Young
    Kim, Seonwoo
    Kim, June-Soo
    On, Young-Keun
    Chun, Mi-Ryung
    Kim, Hee-Jin
    Kim, Jong-Won
    Lee, Soo-Youn
    [J]. PHARMACOGENOMICS, 2007, 8 (04) : 329 - 337
  • [10] A worldwide survey of haplotype variation and linkage disequilibrium in the human genome
    Conrad, Donald F.
    Jakobsson, Mattias
    Coop, Graham
    Wen, Xiaoquan
    Wall, Jeffrey D.
    Rosenberg, Noah A.
    Pritchard, Jonathan K.
    [J]. NATURE GENETICS, 2006, 38 (11) : 1251 - 1260